CRISPR / CAS-related methods and compositions for treatment of beta hemoglobinopathies

AU2026205436A1Pending Publication Date: 2026-07-30EDITAS MEDICINE INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
AU2026205436
Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
Filing Date
2026-07-08
Publication Date
2026-07-30

Smart Images

  • Figure 00000197_0000
    Figure 00000197_0000
  • Figure 00000198_0000
    Figure 00000198_0000
  • Figure 00000199_0000
    Figure 00000199_0000
Patent Text Reader

Abstract

Abstract CRISPR / CAS-related compositions and methods for treatment of p hemoglobinopathies are disclosed. 20 26 20 54 36 08 J ul 2 02 6 2 0 2 6 2 0 5 4 3 6 0 8 J u l 2 0 2 6
Need to check novelty before this filing date? Find Prior Art